David A. Ehrmann

5.7k total citations · 2 hit papers
15 papers, 3.9k citations indexed

About

David A. Ehrmann is a scholar working on Endocrinology, Diabetes and Metabolism, Reproductive Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David A. Ehrmann has authored 15 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Reproductive Medicine and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David A. Ehrmann's work include Ovarian function and disorders (9 papers), Reproductive Biology and Fertility (7 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). David A. Ehrmann is often cited by papers focused on Ovarian function and disorders (9 papers), Reproductive Biology and Fertility (7 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). David A. Ehrmann collaborates with scholars based in United States, Sweden and Italy. David A. Ehrmann's co-authors include Silva Arslanian, Richard S. Legro, Corrine K. Welt, Renato Pasquali, Kathleen M. Hoeger, M. Hassan Murad, Randall B. Barnes, Robert L. Rosenfield, Stephen Burstein and Lynne L. Levitsky and has published in prestigious journals such as New England Journal of Medicine, Endocrine Reviews and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

David A. Ehrmann

15 papers receiving 3.7k citations

Hit Papers

Polycystic Ovary Syndrome 2005 2026 2012 2019 2005 2013 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Polycystic Ovary Syndrome
    2005 1.5k citations David A. Ehrmann New England Journal of Medicine profile →
  2. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
    2013 1.3k citations Richard S. Legro, Silva Arslanian et al. The Journal of Clinical Endocrinology & Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Ehrmann United States 13 3.1k 2.0k 1.0k 570 407 15 3.9k
Stephen Franks United Kingdom 18 3.0k 1.0× 2.3k 1.2× 684 0.7× 521 0.9× 330 0.8× 45 3.7k
José Sancho Spain 26 2.0k 0.6× 1.2k 0.6× 830 0.8× 424 0.7× 506 1.2× 38 3.1k
Ilias Katsikis Greece 32 2.4k 0.8× 1.3k 0.7× 721 0.7× 252 0.4× 498 1.2× 71 3.0k
Rosario Reyna United States 8 2.0k 0.7× 1.3k 0.6× 538 0.5× 261 0.5× 327 0.8× 8 2.4k
Daria Lizneva United States 15 2.2k 0.7× 1.4k 0.7× 413 0.4× 411 0.7× 186 0.5× 23 2.7k
Helen Mason United Kingdom 27 2.7k 0.9× 2.4k 1.2× 533 0.5× 455 0.8× 119 0.3× 45 3.6k
Frank González United States 31 2.3k 0.7× 1.2k 0.6× 574 0.5× 417 0.7× 628 1.5× 72 3.5k
Teresa Cascella Italy 23 1.8k 0.6× 818 0.4× 638 0.6× 223 0.4× 801 2.0× 39 2.4k
James R. Givens United States 27 1.7k 0.5× 964 0.5× 1.4k 1.3× 470 0.8× 189 0.5× 56 2.8k
Franca Fruzzetti Italy 29 1.1k 0.4× 988 0.5× 702 0.7× 435 0.8× 181 0.4× 106 2.2k

Countries citing papers authored by David A. Ehrmann

Since Specialization
Citations

This map shows the geographic impact of David A. Ehrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Ehrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Ehrmann more than expected).

Fields of papers citing papers by David A. Ehrmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Ehrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Ehrmann. The network helps show where David A. Ehrmann may publish in the future.

Co-authorship network of co-authors of David A. Ehrmann

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Ehrmann. A scholar is included among the top collaborators of David A. Ehrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Ehrmann. David A. Ehrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Hannon, Tamara S., Steven E. Kahn, Kristina M. Utzschneider, et al.. (2017). Review of methods for measuring β‐cell function: D esign considerations from the R estoring I nsulin S ecretion ( RISE ) C onsortium. Diabetes Obesity and Metabolism. 20(1). 14–24. 57 indexed citations
2.
Kim, Catherine, Vanita R. Aroda, Ronald Goldberg, et al.. (2017). Androgens, Irregular Menses, and Risk of Diabetes and Coronary Artery Calcification in the Diabetes Prevention Program. The Journal of Clinical Endocrinology & Metabolism. 103(2). 486–496. 10 indexed citations
3.
Hivert, Marie‐France, Christopher Christophi, Paul W. Franks, et al.. (2015). Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program Participants. Diabetes. 65(2). 520–526. 31 indexed citations
4.
5.
Legro, Richard S., Silva Arslanian, David A. Ehrmann, et al.. (2013). Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 98(12). 4565–4592. 1302 indexed citations breakdown →
6.
Ehrmann, David A.. (2005). Polycystic Ovary Syndrome. New England Journal of Medicine. 352(12). 1223–1236. 1461 indexed citations breakdown →
7.
Scott, Michael R. Van, et al.. (2004). Dust mite-induced asthma in cynomolgus monkeys. Journal of Applied Physiology. 96(4). 1433–1444. 30 indexed citations
8.
Ehrmann, David A., Peter E. H. Schwarz, Manami Hara, et al.. (2002). Relationship of Calpain-10 Genotype to Phenotypic Features of Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 87(4). 1669–1673. 81 indexed citations
9.
Ehrmann, David A.. (1999). INSULIN-LOWERING THERAPEUTIC MODALITIES FOR POLYCYSTIC OVARY SYNDROME. Endocrinology and Metabolism Clinics of North America. 28(2). 423–438. 36 indexed citations
10.
Ehrmann, David A.. (1995). Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocrine Reviews. 16(3). 322–353. 335 indexed citations
11.
Barnes, Randall B., Robert L. Rosenfield, David A. Ehrmann, et al.. (1994). Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.. The Journal of Clinical Endocrinology & Metabolism. 79(5). 1328–1333. 234 indexed citations
12.
Rosenfield, Robert L., David A. Ehrmann, Randall B. Barnes, & Zubie Sheikh. (1993). Gonadotropin‐Releasing Hormone Agonist as a Probe for the Pathogenesis and Diagnosis of Ovarian Hyperandrogenism. Annals of the New York Academy of Sciences. 687(1). 162–181. 16 indexed citations
13.
Ehrmann, David A., et al.. (1993). Detection of Functional Ovarian Hyperandrogenism in Women With Androgen Excess. Obstetrical & Gynecological Survey. 48(1). 48–50. 22 indexed citations
14.
Barnes, Randall B., Robert L. Rosenfield, Stephen Burstein, & David A. Ehrmann. (1989). Pituitary-Ovarian Responses to Nafarelin Testing in the Polycystic Ovary Syndrome. New England Journal of Medicine. 320(9). 559–565. 249 indexed citations
15.
Ehrmann, David A.. (1989). Limitations to the Use of a Sensitive Assay for Serum Thyrotropin in the Assessment of Thyroid Status. Archives of Internal Medicine. 149(2). 369–369. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen Franks Breakdown of academic impact, for papers by José Sancho Breakdown of academic impact, for papers by Ilias Katsikis Breakdown of academic impact, for papers by Rosario Reyna Breakdown of academic impact, for papers by Daria Lizneva Breakdown of academic impact, for papers by Helen Mason Breakdown of academic impact, for papers by Frank González Breakdown of academic impact, for papers by Teresa Cascella Breakdown of academic impact, for papers by James R. Givens Breakdown of academic impact, for papers by Franca Fruzzetti
Rankless by CCL
2026